Tobramycin Solution
Product Images NDC 59651-129

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 59651-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Relative Change From Baseline In Fev1% Predicted (Tobramycin Fig1)

A line graph depicting average relative change in FEV1 percentage predicted over 24 weeks, comparing Tobramycin inhalation solution versus placebo in two studies. The x-axis shows time in weeks, and the y-axis shows FEV1 percentage change. Tobramycin groups exhibit a marked increase compared to placebo groups across the period.*

FDA Label Image

Figure H (Tobramycin Fig10)

An instructional diagram showing a hand holding an electrical plug about to insert it into a wall outlet with two sockets. The image indicates the direction of plugging with an arrow pointing toward the outlet.*

FDA Label Image

Figure I (Tobramycin Fig11)

An instructional illustration showing how to remove the bottom tab from a Tobramycin inhalation solution ampule by twisting. The image depicts hands holding the ampule and a direction arrow indicating the removal motion for administration preparation.*

FDA Label Image

Figure J (Tobramycin Fig12)

An instructional illustration showing a hand holding a vial with a small opening at the bottom, positioned above a small inhalation device. The vial is being inserted or placed into the top opening of the inhaler, indicating preparation or loading of the respiratory solution into the device.*

FDA Label Image

Figure K (Tobramycin Fig13)

An instructional diagram depicting the assembly of a nebulizer for inhalation solution delivery. The illustration identifies parts including the nebulizer top with a semi-circle marker, stem, nebulizer cup, and nebulizer outlet, showing how the nebulizer top attaches to the nebulizer cup with a clockwise twist.*

FDA Label Image

Figure L (Tobramycin Fig14)

An instructional diagram showing the assembly of a nebulizer for respiratory inhalation. The image labels the mouthpiece, nebulizer outlet, and nebulizer cup, illustrating how the mouthpiece attaches to the nebulizer outlet on the nebulizer cup.*

FDA Label Image

Figure M (Tobramycin Fig15)

An instructional diagram illustrating parts of a respiratory inhalation device for Tobramycin solution. The diagram highlights the inspiratory valve cap, showing its removal or placement on the device's main body, including the mouthpiece and handle.*

FDA Label Image

Figure N (Tobramycin Fig16)

An instructional diagram showing the assembly step of a respiratory inhalation device. It illustrates connecting the lower part of the mouthpiece by aligning the air intake section with an inhaler base, indicated by upward arrows directed towards the connection point.*

FDA Label Image

Figure O (Tobramycin Fig17)

An instructional illustration showing a hand pressing a button or switch on a Pulmo-Aide device, which is a medical nebulizer used for respiratory inhalation therapy. The drawing highlights the interaction with the device's control mechanism.*

FDA Label Image

Figure P (Tobramycin Fig18)

An instructional illustration showing a respiratory inhalation device emitting a mist or aerosol from its mouthpiece. The device is depicted in a side view with simplified features, including a mouthpiece, chamber, and connecting tube, indicating its use for delivering a medicinal solution via inhalation.*

FDA Label Image

Figure Q (Tobramycin Fig19)

An instructional illustration showing a person using a respiratory inhalation device. The image highlights the use of a nose clip while inhaling from the device mouthpiece, indicating a step in the administration process for inhaled medications.*

FDA Label Image

Figure 2: Absolute Change From Baseline In Log10 Cfus (Tobramycin Fig2)

A line graph depicting the average change of Log10 CFUs over 24 weeks, comparing Tobramycin Inhalation Solution to placebo in two different studies. The x-axis represents time in weeks, and the y-axis shows the average change of Log10 CFUs. The graph includes labels indicating periods when patients were on the drug.*

FDA Label Image

Package Label-principal Display Panel (300 mg per 5 mL)

Label for Tobramycin Inhalation Solution, USP 300 mg per 5 mL single-dose ampules. The solution is for inhalation only by nebulizer, preservative-free, available as 4 x 5 mL single-dose ampules. Distributed by Aurobindo Pharma USA, Inc., with storage instructions to refrigerate at 2 to 8°C and protect from intense light.*

FDA Label Image

Package Label-principal Display Panel (300 mg per 5 mL)

Label for Tobramycin Inhalation Solution, USP 300 mg per 5 mL single-dose ampules. The packaging indicates it is for inhalation only by nebulizer, contains no preservatives, and should be stored in a refrigerator. The label shows the NDC 59651-129-56 and is distributed by Aurobindo Pharma USA, Inc. It contains 56 single-dose 5 mL ampules (28-day supply) with 4 ampules per pouch and 14 pouches per carton.*

FDA Label Image

Figure A (Tobramycin Fig3)

Illustration showing a respiratory inhalation device setup including labeled parts: air compressor, nebulizer cup, inspiratory valve cap, ampule, mouthpiece, clean paper or cloth towels, and tubing. The image depicts components used for inhalation therapy, possibly related to TOBRAMYCIN solution administration.*

FDA Label Image

Figure B (Tobramycin Fig4)

An instructional diagram shows hands holding two plastic ampules labeled 'Tobramycin Inhalation Solution IP 300 mg/5 mL,' demonstrating how to open the ampules by twisting off the top portion in opposite directions for inhalation use.*

FDA Label Image

Figure C (Tobramycin Fig5)

Packaging label of TOBRAMYCIN 300 mg/5 mL solution for respiratory inhalation showing a portion of a container with a marked expiration date area. The label indicates distribution by Aurobindo Pharma USA, Inc., East Windsor, NJ 08520.*

FDA Label Image

Figure D (Tobramycin Fig6)

An instructional line drawing showing assembly steps for a respiratory inhalation nebulizer. It depicts hands removing the nebulizer top from the nebulizer cup, with labeled components including the mouthpiece, inspiratory valve cap, and tubing.*

FDA Label Image

Figure E (Tobramycin Fig7)

An instructional illustration showing the assembly of a respiratory inhalation device for Tobramycin solution. It depicts a hand inserting a nebulizer insert into a nebulizer cup with labeled parts: 'Top,' 'Nebulizer Insert,' and 'Nebulizer Cup.' The diagram guides proper assembly for inhalation use.*

FDA Label Image

Figure F (Tobramycin Fig8)

Illustration showing a nebulizer cup with a top component on a clean surface, labeled as clean paper or cloth towels. The diagram depicts parts of the respiratory inhalation device used for administering tobramycin solution.*

FDA Label Image

Figure G (Tobramycin Fig9)

An instructional illustration showing a hand retrieving or placing an item into a Parno-Aide storage or dispensing device. The device features a front panel or cover being lifted or opened to access the contents inside.*

FDA Label Image

Chemical Structure (Tobramycin Str)

Chemical structure diagram of tobramycin, showing its molecular components and arrangement.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.